FEM1B
Basic information
Region (hg38): 15:68277745-68295862
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FEM1B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 13 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 0 | 1 |
Variants in FEM1B
This is a list of pathogenic ClinVar variants found in the FEM1B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-68278456-C-T | Benign (Dec 31, 2019) | |||
15-68278526-G-A | not specified | Uncertain significance (May 31, 2023) | ||
15-68289621-G-A | not specified | Uncertain significance (Jul 14, 2023) | ||
15-68289795-A-G | not specified | Uncertain significance (Mar 18, 2024) | ||
15-68289857-A-G | not specified | Uncertain significance (Aug 22, 2023) | ||
15-68289870-G-C | not specified | Uncertain significance (Sep 14, 2022) | ||
15-68289887-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
15-68289957-T-C | Uncertain significance (Apr 27, 2021) | |||
15-68290095-G-A | not specified | Uncertain significance (Jul 05, 2022) | ||
15-68290187-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
15-68290232-G-A | not specified | Uncertain significance (Jan 24, 2024) | ||
15-68290311-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
15-68290403-T-C | not specified | Uncertain significance (May 01, 2024) | ||
15-68290667-A-G | not specified | Uncertain significance (Oct 29, 2021) | ||
15-68290803-G-A | not specified | Uncertain significance (Aug 04, 2023) | ||
15-68290889-A-C | not specified | Uncertain significance (May 29, 2024) | ||
15-68290925-G-T | Uncertain significance (Dec 06, 2023) | |||
15-68290961-G-C | not specified | Uncertain significance (Apr 08, 2024) | ||
15-68291045-G-A | not specified | Uncertain significance (Apr 29, 2024) | ||
15-68291075-A-G | not specified | Uncertain significance (Feb 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FEM1B | protein_coding | protein_coding | ENST00000306917 | 2 | 18063 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.349 | 0.651 | 125744 | 0 | 4 | 125748 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.62 | 160 | 351 | 0.456 | 0.0000184 | 4145 |
Missense in Polyphen | 32 | 130.2 | 0.24578 | 1512 | ||
Synonymous | -0.409 | 139 | 133 | 1.05 | 0.00000694 | 1244 |
Loss of Function | 2.99 | 4 | 17.5 | 0.228 | 9.81e-7 | 226 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.00000881 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of an E3 ubiquitin-protein ligase complex, in which it may act as a substrate recognition subunit. Involved in apoptosis by acting as a death receptor-associated protein that mediates apoptosis. Also involved in glucose homeostasis in pancreatic islet. Functions as an adapter/mediator in replication stress-induced signaling that leads to the activation of CHEK1. {ECO:0000269|PubMed:10542291, ECO:0000269|PubMed:19330022}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.69
Haploinsufficiency Scores
- pHI
- 0.252
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.607
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.948
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fem1b
- Phenotype
- reproductive system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- apoptotic process;protein ubiquitination;post-translational protein modification;regulation of ubiquitin-protein transferase activity;branching involved in prostate gland morphogenesis;epithelial cell maturation involved in prostate gland development;regulation of extrinsic apoptotic signaling pathway via death domain receptors;regulation of DNA damage checkpoint
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol
- Molecular function
- ubiquitin-protein transferase activity;death receptor binding;protein binding